This site is intended for healthcare professionals
Food Allergy_Selection of foods and allergies
Food Allergy Learning Zone
Declaration of sponsorship Novartis Pharma AG

Food Allergy Symposium at EAACI 2023*

Declaration of sponsorship Novartis Pharma AG
Read time: 5 mins
Last updated:30th May 2023
Published:3rd Apr 2023

Evolving Patient Journeys in Food Allergy

Friday, 9 June 2023: 12:00–13:00 CEST

Agenda Friday, 9 June 2023
12:00 pm Welcome and introductions
Professor Alexandra Santos
12:05 pm Improving confidence – managing anxieties around living with food allergies
Professor Alexandra Santos and Doctor Rebecca Knibb
12:18 pm Integrating OIT into clinical practice
Pablo Rodríguez del Río, MD PhD
12:31 pm Practical management in adult patients
Professor Margitta Worm
12:44 pm Q&A and panel discussion
Chaired by Professor Alexandra Santos
12:59 pm Closing statement
Professor Alexandra Santos

Have you registered for this symposium on optimising the patient experience at each stage of their food allergy journey? According to estimates, approximately 11 to 26 million Europeans suffer from food allergies with an estimated global prevalence of 240 to 550 million food-allergic individuals1. This live symposium will provide insight into emerging approaches to improve the diagnosis, treatment and prevention of food allergies. Discover diagnostic strategies that may improve the patient experience, learn about new therapeutic approaches and explore how these strategies may reduce some of the anxiety associated with strict avoidance diets in patients with food allergies. During the event, you will be able to participate in a Q&A session and listen to a panel discussion in which experts provide insights based on their own clinical experience.

To attend this event live, you must register directly with EAACI. Click here to register now!

Not able to join live? Sign up on the form below to get involved by submitting your questions to the experts, and receive an email when this symposium is published on Medthority to receive your CME credit!*

Optional: I confirm that I am happy to receive relevant Medthority updates by email
An error has occurred while getting captcha image

This symposium aims to explore and broaden your current understanding in several key areas when treating patients with food allergies. Through attending this symposium, you will gain 1 CME-CPD point through EACCME®*.

After participating in this educational programme, learners will be able to:

  • Identify appropriate support pathways to ease patient anxiety around the management of food allergies
  • Recognise the benefits and risks of oral immunotherapies for the treatment of food allergies
  • Identify practical management techniques which can be used in the treatment of food allergies

Watch the EAACI 2022 Symposium ‘Improving patients’ journeys in food allergy’ here.

Alexandra Santos V2.pngProfessor Alexandra Santos

Professor Alexandra Santos is Professor of Paediatric Allergy at King’s College London and Honorary Consultant in Paediatric Allergy at the Evelina London Children’s Hospital in London, UK.

Disclosures: Professor Santos has grants from Medical Research Council (MR/M008517/1; MC/PC/18052; MR/T032081/1), Food Allergy Research and Education (FARE), the NIH, Asthma UK (AUK-BC-2015-01), Immune Tolerance Network/National Institute of Allergy and Infectious Diseases (NIAID, NIH), the European Commission and the Wellcome Trust; consultancy and/or speaker fees from Thermo Scientific, Nutricia, Infomed, Novartis, Allergy Therapeutics, Bühlmann, as well as research support from Bühlmann and Thermo Fisher Scientific through a collaboration agreement with King's College London

Doctor Rebecca Knibb.pngDoctor Rebecca Knibb

Dr Rebecca Knibb is an Associate Professor in Health Psychology at Aston University. Birmingham, UK.

Disclosures: Dr Rebecca Knibb is in receipt of grants/research supports from Aimmune, National Peanut Board, Novartis, Food Standards Agency, National Institute for Health Research and is also in receipt of honoraria or consultation fees from Aimmune, Nutricia and has participation in a company sponsored speaker’s bureau with DBV Technologies

Pablo Rodríguez del Río.pngPablo Rodríguez del Río, MD, PhD

Pablo Rodríguez del Río, MD, PhD is a specialist in allergology at the Infantil Niño Jesús university paediatric hospital, Madrid, Spain.

Disclosures: Pablo Rodríguez del Río MD, PhD is in receipt of grants or research support from Aimmune Therapeutics and is in receipt of honoraria or consultation fees from FAES. Dr Rodríguez del Río has also participated in a company-sponsored speaker’s bureau for SK, FAES, Novartis, ALK-Abelló, LETI and Aimmune Therapeutics, Sanofi, Stallergenes, DBV

Prof. Dr. med. Margitta Worm.pngProf. Dr. med. Margitta Worm

Prof. Dr. med. Margitta Worm is a university professor for immune modulation of allergic diseases at Charité – Universitätsmedizin Berlin, Germany.

Disclosures: Prof. Dr. med. Margitta Worm is in receipt of honoraria or consultation fees grants or research support from Novartis Pharma GmbH, Sanofi-Aventis Deutschland GmbH, DBV Technologies S.A, Aimmune Therapeutics UK Limited, Regeneron Pharmaceuticals,Inc, Leo Pharma GmbH, Boehringer Ingelheim Pharma GmbH &Co.KG, ALK-Abelló Arzneimittel GmbH, Lilly Deutschland GmbH, Kymab Limited, Amgen GmbH, Abbvie Deutschland GmbH & Co. KG, Pfizer Pharma GmbH, Mylan Germany GmbH (A Viatris Company), AstraZeneca GmbH and GlaxoSmithKline GmbH & Co. KG.


  1. Statistics and Figures. Allergy UK | National Charity. Published 2022. Assessed 23 March 2023.

*This event is accredited under the Hamburg Medical Association and EACCME®.